A thread through the archive
Essays tagged “GLP-1 drugs”. Follow an idea across the archive.
Scott shares his monthly collection of interesting links from around the internet, covering topics from Jeremy Bentham's linguistic legacy to AI developments, with characteristic commentary and fact-checking caveats.
Scott analyzes the implications of the FDA ending compounded GLP-1 weight loss drugs, which have provided a cheaper alternative to official channels for the past three years, and examines various responses from both compounding pharmacies and pharmaceutical companies.
Scott Alexander examines the surprisingly broad effects of GLP-1 drugs like Ozempic, exploring their mechanisms and speculating on why they seem to impact so many different conditions.